Friday, October 23, 2015


 Poster Session: Nursing/Survivorship 
P01   Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: Design of a multicenter, randomized controlled trial
Daniela E.E. Hahn, The Netherlands
P02   Maximising nurses' impact on women living well after breast cancer
Lee Kennedy, Australia
P03   A heat-reduction mastectomy bra and its performance evaluation with a core temperature pill sensor
Kaoru Leung, Hong Kong
P04   Survivorship care involving a nurse-led survivorship consultation, community support and shared care with primary practitioners
Kerry Shanahan, Australia
Poster Session: Radiology/Screening
P05   Educational intervention for women's adhesion to mammographic screening in São Paulo city
Eduardo Blanco Cardoso, Brazil
P06   Background parenchymal enhancement on breast MRI and mammographic breast  density: Correlation with tumour characteristics
Bo Hwa Choi, Korea
P07   False positive or negative results of shear-wave elastography in differentiating benign from malignant breast masses: Analysis of clinical and ultrasonographic characteristics
Bo Hwa Choi, Korea
P08   Treatment intensity differences in screen-detected and community-detected Early Stage Breast Cancer (ESBC)
Kenneth Jack Elder, Australia
P09   Status and results of breast cancer screening mammography in women 20 to 69 years of age in Isfahan, Iran
Ghasem Yadegarfar, UK
P10   Efficacy of breast cancer screening in Iranian women aged 20-69: A prospective trial study
Ghasem Yadegarfar, UK
Poster Session: Surgery
P11   Implant salvage in breast reconstruction: A novel technique
Elisabeth Elder, Australia
P12   Breast reconstruction in Australia: Documenting the evidence on access
Kathy Flitcroft, Australia
P13   New Zealand women are perceived as stoic and not too concerned about having a mastectomy: Has the time come to dispel this popular myth?
Elizabeth Foo, New Zealand

Molecular subtype is a predictor of residual axillary nodal disease following neoadjuvant chemotherapy for breast cancer
Justin James, Australia

P15   Socioeconomic determinants influencing immediate breast reconstruction in an Australian tertiary public hospital
Chere McCamley, Australia
P16   Margin preferences and attitudes to re-excision of breast surgeons of Australia and New Zealand in breast conserving surgery
Kowsalya Murugappan, Australia
P17   Oncological outcome after nipple sparing mastectomy and immediate reconstruction with breast cancer
Jai Min Ryu, Korea
P18   Optimal Care Pathway for people with breast cancer
Christobel Saunders, Australia
P19   Evaluation of the use of electrocautery vs. harmonic focus in seroma formation after axillary lymph node dissection
Selwyn Selvendran, Australia
P20   Breast parenchyma preservation: How much normal tissue are we excising?
Thomas Surya Suhardja, Australia
P21   Impact of surgical factors on re-operation and resection ratio for patients treated with primary breast conserving surgery: A retrospective cohort study
Natarajan Vaithilingam, UK
P22   Seven day drains versus four day drains in breast cancer surgery: The incidence of seroma at the breast centre, Sir Charles Gairdner Hospital, Perth
Von Hagt, Australia
P23   Experience with intra-operative imaging and margin re-excisions in breast conserving surgery
Davina Von Hagt, Australia
P24   Breast conservation in multicentric tumors: A road less travelled by
Vuthaluru, India
P25   Optimizing sentinel lymph node biopsy in women with early breast cancer
Wang, China

Saturday, October 24, 2015

 Poster Session: Basic Science
P01   The comparison of growth dynamic in two human carcinoma cell lines; HCT-116 (a colon cancer cell line) and MCF-7 (a breast cancer cell line): Can be any crosstalk between them in growth regulation
Narges Amirjamshidi, Iran
P02   Adipocytes can induce epithelial-mesenchymal transition in breast cancer
Yu Kyung Lee, Korea
P03    The synthesis and biochemical evaluation of dual inhibitors of the cytochrome P450 enzymes aromatase and 17α-hydroxylase/17,20-lyase
Raza Muhammad, UK
P04   Prognostic significance of lymphatic vessel density in breast cancer patients receiving different treatment schedules
Joanna Anna Niemiec, Poland
P05   Expression and polymorphisms in Toll-Like Receptor 4 (TLR-4) gene as predictors of clinical outcomes in estrogen negative receptor post-menopausal breast cancer patients
Abdelhabib Semlali, Saudi Arabia
P06   A study of endoplasmic reticulum stress response in breast cancer  patients on neoadjuvant chemotherapy
Varna Taranikanti, Oman
P07   Detection of serum HER2/neu in breast cancer patients, Yangon General Hospital, Myanmar
Zin Zin Thu, Myanmar
Poster Session: Medical Oncology
P08   Potential biological markers of trastuzumab resistance in HER2-overexpressing breast cancer patients
Aleksandra Ambicka, Poland
P09   Is the use of dark nail polish relevant for patients on taxanes?
Gillian Blanchard, Australia
P10   Prognostic values of loss of estrogen or progesterone receptors in luminal B HER2 negative breast cancer
Junyub Kim, Korea
P11   Recurrence risk in small, node-negative, early breast cancer
Andrea Narsanska, Czech Republic
P12   Is an asymptomatic valvular insufficiency a clinical prognostic marker in HER2- positive breast cancer patients treated with trastuzumab in adjuvant setting?
Joanna Anna Niemiec, Poland
P13   Metaplastic breast carcinoma: A single center experience at a tertiary care centre in Pakistan
 Samoon, Pakistan
P14   Implementation strategies to optimize the use of Neoadjuvant Systemic Therapy (NAST) for operable breast cancer
 Sproule, Australia
P15   Combination chemotherapy with mitomycin c and methotrexate is still active against metastatic breast cancer even after heavy treatment with anthracycline, taxane, capecitabine, eribulin, vinorelbine, and bevacizumab
 Tanabe, Japan
Poster Session: Radiation Oncology
P16   Voluntary breath hold in left-sided breast cancer radiation therapy: Is it safe?
Lani Attwood, Australia
P17   Post mastectomy radiation in breast cancer patients with T1-T2 and 1-3 axillary lymph nodes: Is there a role for radiation therapy?
Ashish Jakhetiya, India
P18   Stereotactic ablative body radiotherapy for oligometastatic breast cancer: A case series of four patients treated with isolated sternal metastasis
Adam Miodek, Australia
P19   Intraoperative radiotherapy in early breast cancer: Loco-regional failure analysis
Mariana Steiner, Israel
P20   How to make outer margin for breast cancer in IMRT
Sun Young Ma, Korea
Poster Session: Epidemiology
P21   Should women with a projected 5-year risk of developing breast cancer = 1.4% be offered pharmacologic risk reduction?
Richard Allman, Australia
P22   Atypical ductal hyperplasia: An 18 year experience
Melvyn Ang, Australia
P23   Can we apply the guidelines derived from western database to other ethnic groups? A gail model based evaluation of geo-ethnic variations in breast cancer
Pragyat Thakur, India
P24   Relationship between  breast cancer metastasis and each indexes of lipid phase were analyzed to investigate predictive value of lipid phase in breast cancer metastasis
Mengqiang Zhou, China